Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD) (PANTHER)

Nycomed

Status: Completed

Conditions: Gastroesophageal Reflux Disease

Treatments: Drug: Pantoprazole

Study type: Observational

Funder types: Industry

Identifiers

NCT00561730

PAN 20/40 Panther 07/10

Details and patient eligibility

About

The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).

Enrollment: 1,995 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Main inclusion criteria:

• Outpatients with erosive gastro-esophageal reflux disease (eGERD according to Los Angeles classification grade A-D) or non-erosive reflux disease (NERD)

Main exclusion criteria:

• Criteria as defined in the Summary of Product Characteristics (Chapter 4.3)

Trial design

1,995 participants in 1 patient group

Pantoprazole

Description:

All patients enrolled

Treatment:

Drug: Pantoprazole